CIK 0001854270 · <br>Emerging growth company
Senti Biosciences Holdings, Inc.
Sign in to watch- Ticker
- SNTI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862437900
- Phone
- (650) 239-2030
- Business address
- 2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Senti Biosciences, Inc., Senti Biosciences, Inc.\, Dynamics Special Purpose Corp.
- 8-K Event Material agreement · Delisting notice
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- ARS Other Annual Report to Security Holders
- PREM14A Deal PREM14A
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- S-3/A Offering Registration Statement
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Results of operations · Change in control · Regulation FD disclosure · Other events
- S-3 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 15-12G Other 15-12G
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Change in control
- EFFECT Other Notice of Effectiveness
Page 2 of 19 · 368 filings